SAN DIEGO, March 11, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) will participate at the Stifel 2025 Virtual CNS Forum at 1:30 p.m. Eastern Time on Tuesday, March 18, 2025. Chief ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on March 10, 2025, the Compensation Committee of the ...

On Dec 12, 2024, the US Food and Drug Administration (FDA) approved crinecerfont for adults and paediatric patients with ...

Boys and young adult male patients with congenital adrenal hyperplasia receiving glucocorticoid treatment have lower bone ...

HBM Alpha Therapeutics Inc. signed a potential $395 million licensing deal Feb. 26 with an unnamed “business partner” for its endocrine asset, HAT-001, adding another contender to the congenital ...

I am passionate about developing new medicines and look forward to using my experience and network to help guide the team as they prepare to enter the clinic with their potentially best-in-class MC2 ...

Inc., an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142), announced a strategic collaboration and license agreement with a business partner to advance novel therapies ...

Electroretinograms, however, are usually not detectable in Leber congenital amaurosis, and signals from a small region treated with gene therapy might be lost in noise. For this study, 7 investigators ...

There are 2 adrenal glands, one above each kidney. They make hormones that help the body work properly and are vital to life. Most tumours of the adrenal gland are called adenomas. These are not ...

Scientists have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect. Scientists at the Icahn School of Medicine at Mount Sinai and ...

Congenital heart disease or defect is a common type of birth defect that needs medical attention. The exact cause is unclear, but it may be connected to genetic factors or the mother’s health ...

Get Instant Summarized Text (Gist) Simple congenital heart diseases, particularly patent foramen ovale (PFO), are linked to a higher risk of epilepsy. An analysis of 10,914 patients revealed ...